|
2024
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Scientific research in the field of prevention and treatment of cardiovascular disease; providing... |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of diseases and disorders of the res... |
|
2023
|
P/S
|
Computer software platforms, recorded, for physicians and healthcare practitioners to support cli... |
|
|
P/S
|
Computer software platforms for physicians and healthcare practitioners to support clinical decis... |
|
|
Invention
|
Pharmaceutical composition, methods for treating and uses thereof.
The invention relates to soli... |
|
|
Invention
|
Nebulizer.
A nebulizer for nebulizing a liquid includes: a container containing multiple doses o... |
|
|
Invention
|
Nebulizer and cartridge.
A cartridge for a nebulizer having a connection element, includes: a co... |
|
|
Invention
|
Anti-trkb antibodies.
The present invention relates to novel agonistic anti-TrkB antibodies and ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system |
|
|
Invention
|
Pharmaceutical composition, methods for treating and uses thereof.
The present invention relates... |
|
|
Invention
|
Viral vector for the targeted transfer of genes in the brain and spinal cord.
The invention rela... |
|
|
Invention
|
Methods for treating and pharmaceutical compositions.
The invention relates to methods for impro... |
|
|
Invention
|
Methods of treating diseases.
The invention relates to the uses of an SGLT-2 inhibitor, for exam... |
|
|
P/S
|
Providing temporary use of online non-downloadable webbased applications |
|
|
P/S
|
Medical and scientific research in the field of
pharmaceutical preparations; providing medical a... |
|
|
Invention
|
Methods for the treatment of nash with advanced fibrosis and/or cirrhosis. dsRNAi oligonucleotide... |
|
|
Invention
|
Dosage regimen for the treatment of nash. dsRNAi oligonucleotides can be used in methods for the ... |
|
|
Invention
|
Cardio- and renoprotective antidiabetic therapy.
The present invention relates to a certain DPP-... |
|
|
Invention
|
Novel transposase system. Acyrthosiphon pisum (AP) or Aphis craccivora (AC)Acyrthosiphon pisum (A... |
|
|
Invention
|
Glucagon analogues as long-acting glp-1/glucagon receptor agonists in the treatment of fatty live... |
|
|
P/S
|
Downloadable computer software platform for patient and physician engagement; downloadable mobile... |
|
|
P/S
|
Downloadable computer software platform for patient and
physician engagement; downloadable mobil... |
|
|
P/S
|
Medical and scientific research in the field of pharmaceutical preparations; providing medical an... |
|
|
Invention
|
Use of biomarkers in the treatment of fibrotic conditions with a pde4b-inhibitor. The PDE4-inhibi... |
|
|
Invention
|
Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors.
Disclosed are heteroarom... |
|
|
P/S
|
Medical and scientific research in the field of metabolic
disease and liver disease; providing m... |
|
|
P/S
|
Medical and scientific research in the field of metabolic disease and liver disease; providing me... |
|
|
P/S
|
Downloadable electronic publications in the field of treatment of metabolic, renal and cardiovasc... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali... |
|
|
Invention
|
New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors. ... |
|
|
Invention
|
Myeloid-derived growth factor for use in treating cardiogenic shock. The present invention relate... |
|
|
Invention
|
Pharmaceutical composition, methods for treating and uses thereof.
The invention relates to the ... |
|
|
Invention
|
Antibody molecules for cancer treatment.
The present invention relates to novel anti-PD1 and ant... |
|
|
Invention
|
Scalable process for the preparation of a glyt-1 inhibitor.
This invention relates to a syntheti... |
|
|
Invention
|
A scalable process for the preparation of a glyt-1 inhibitor. This invention relates to a synthet... |
|
|
Invention
|
Combination therapy comprising long acting glp-1/glucagon and npy2 receptor agonists.
A combinat... |
|
|
Invention
|
Pharmaceutical formulations of nintedanib for intraocular use.
Formulations and intravitreal imp... |
|
|
Invention
|
Combination therapy comprising long acting glp-1/glucagon and npy2 receptor agonists. 216γ22 (I) ... |
|
|
Invention
|
Pharmaceutical formulations of nintedanib for intraocular use. Formulations and intravitreal impl... |
|
|
Invention
|
Artificial mirnas targeting multiple hydrolases. The present invention relates to an artificial m... |
|
|
Invention
|
Use of anti-il-36r antibodies for treatment of inflammatory bowel disease.
The present invention... |
|
|
Invention
|
Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase... |
|
|
P/S
|
Scientific research in the field of prevention and treatment of renal diseases; providing medical... |
|
|
Invention
|
Binding molecules for the treatment of cancer.
The present invention relates to novel binding mo... |
|
|
Invention
|
Binding molecules for the treatment of cancer. The present invention relates to novel binding mol... |
|
|
Invention
|
New combination of active agents for the treatment of progressive fibrosing interstitial lung dis... |
|
|
Invention
|
Hsd17b13 inhibitors. The present invention encompasses heteroaryl substituted 2,6-difluorophenol ... |
|
|
Invention
|
Recombinant rhabdovirus encoding for ccl21.
The present invention relates to the field of oncoly... |
|
|
Invention
|
Human antibodies to tn antigen.
The present invention provides compositions for the production o... |
|
|
Invention
|
Combination treatment.
The present invention relates to combination treatments for cystic fibros... |
|
|
Invention
|
Anti-nrp1a antibodies and their uses for treating eye or ocular diseases.
Disclosed are antibodi... |
|
|
Invention
|
Tumor antigens, compounds comprising the tumor antigens and uses thereof.
The present invention ... |
|
2021
|
Invention
|
Administration device for in particular intravitreal administration of a fluid.
An administratio... |
|
|
Invention
|
Viral vectors and nucleic acids for use in the treatment of ild, pf-ild and ipf.
Viral vector co... |
|
|
Invention
|
Systems and methods for producing a biologic molecule with hydrocyclone cell retention device.
S... |
|
|
Invention
|
Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of... |
|
|
Invention
|
Viral vectors and nucleic acids for regulated gene therapy.
This invention generally relates to ... |
|
2020
|
Invention
|
Novel tetrazoles.
This invention relates to tetrazoles and their use as inhibitors of TRPA1 acti... |
|
|
Invention
|
Bioreactor or fermenter for the culturing of cells or microorganisms in suspension in industrial ... |
